Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | CASP1 | P29466 | 3/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | RECQL | P46063 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6051251 | 0.76 | TDP1 (0.60) | ALDH1A1CYP3A4HPGDTDP1HSD17B10 | |
| SCHEMBL20356052 | 0.76 | CASP1 (0.37) | ALDH1A1CYP3A4HPGDTDP1TSHR | |
| SCHEMBL4650278 | 0.75 | TTR (0.55) | ALDH1A1CYP3A4HPGDTDP1TSHR | |
| SCHEMBL17000438 | 0.75 | TTR (0.55) | ALDH1A1CYP3A4HPGDTDP1TSHR | |
| SCHEMBL21974454 | 0.74 | TDP1 (0.62) | ALDH1A1CYP3A4HPGDTDP1TSHR | |
| SCHEMBL9231280 | 0.74 | ALDH1A1 (0.54) | ALDH1A1CYP3A4HPGDTDP1TSHR | |
| SCHEMBL24254785 | 0.74 | HPRT1 (0.43) | ALDH1A1CYP3A4HPGDTDP1HSD17B10 | |
| SCHEMBL21499706 | 0.74 | HPRT1 (0.43) | ALDH1A1CYP3A4HPGDTDP1HSD17B10 | |
| SCHEMBL2023308 | 0.73 | PARP1 (0.41) | ALDH1A1CYP3A4HPGDTDP1TSHR | |
| SCHEMBL25990463 | 0.72 | TDP1 (0.39) | ALDH1A1CYP3A4HPGDTDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106232214-B | Composite polyamide membrane post-treated with nitrous acid | 陶氏环球技术有限责任公司 | 2021-01-15 | — | — | CN | disclosed |
| US-10793584-B2 | Naphthobischalcogenadiazole derivative and production method therefor | OSAKA UNIVERSITY (JP) | 2020-10-06 | — | — | US | disclosed |
| CN-105848758-B | Separation of hydrocarbons from aqueous mixtures using fouling resistant reverse osmosis membranes | 陶氏环球技术有限责任公司 | 2020-01-17 | — | — | CN | disclosed |
| US-20190337966-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | OSAKA UNIVERSITY (JP) | 2019-11-07 | — | — | US | disclosed |
| CN-105848759-B | Desalting an aqueous mixture containing nanosized particles using a fouling resistant reverse osmosis membrane | 陶氏环球技术有限责任公司 | 2019-04-02 | — | — | CN | disclosed |
| EP-3142777-B1 | COMPOSITE POLYAMIDE MEMBRANE POST TREATED WITH NITROUS ACID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-10-24 | — | — | EP | disclosed |
| EP-3092057-B1 | TREATMENT OF AQUEOUS MIXTURES CONTAINING ANIONIC SURFACTANTS USING FOULING RESISTANT REVERSE OSMOSIS MEMBRANE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-09-19 | — | — | EP | disclosed |
| EP-3092056-B1 | DESALINATION OF AQUEOUS MIXTURE CONTAINING NANO-SIZED PARTICLES USING FOULING RESISTANT REVERSE OSMOSIS MEMBRANE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-08-01 | — | — | EP | disclosed |
| WO-2018123207-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | 国立大学法人大阪大学 | 2018-07-05 | — | — | WO | disclosed |
| EP-3077088-B1 | METHOD FOR FORMING A COMPOSITE POLYAMIDE MEMBRANE POST TREATED WITH NITRIOUS ACID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-12-27 | — | — | EP | disclosed |
| US-20160304363-A1 | SEPARATION OF HYDROCARBONS FROM AQUEOUS MIXTURE USING FOULING RESISTANT REVERSE OSMOSIS MEMBRANE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-10-20 | — | — | US | disclosed |
| US-20160303516-A1 | DESALINATION OF AQUEOUS MIXTURE CONTAINING NANO-SIZED PARTICLES USING FOULING RESISTANT REVERSE OSMOSIS MEMBRANE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-10-20 | — | — | US | disclosed |
| EP-3077088-A1 | COMPOSITE POLYAMIDE MEMBRANE POST TREATED WITH NITRIOUS ACID | Dow Global Technologies LLC (US) | 2016-10-12 | — | — | EP | disclosed |
| US-20160271567-A1 | COMPOSITE POLYAMIDE MEMBRANE POST TREATED WITH NITRIOUS ACID | THE DOW CHEMICAL COMPANY | 2016-09-22 | — | — | US | disclosed |
| CN-105848759-A | Desalting an aqueous mixture containing nanosized particles using a fouling resistant reverse osmosis membrane | 陶氏环球技术有限责任公司 | 2016-08-10 | — | — | CN | disclosed |
| CN-105848758-A | Separation of hydrocarbons from aqueous mixtures using fouling resistant reverse osmosis membranes | 陶氏环球技术有限责任公司 | 2016-08-10 | — | — | CN | disclosed |
| WO-2015175256-A1 | COMPOSITE POLYAMIDE MEMBRANE POST TREATED WITH NITROUS ACID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-11-19 | — | — | WO | disclosed |
| EP-0710684-B1 | Preparation process of polyhydroxycarboxylic acid | MITSUI CHEMICALS INC (JP) | 2001-01-31 | — | — | EP | disclosed |
| US-5770683-A | Preparation process of polyhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-06-23 | — | — | US | disclosed |
| EP-0710684-A2 | Preparation process of polyhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-05-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793584-B2 | Naphthobischalcogenadiazole derivative and production method therefor | CYP24A1, CYP26B1, CYP21A2 | ALDH1A1 600/4885CYP3A4 389/4885HPGD 815/4885 |
| US-20190337966-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | CYP24A1, CYP26B1, CYP21A2 | ALDH1A1 600/4885CYP3A4 389/4885HPGD 815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.